Tiger Woods will not play the Memorial Tournament at Muirfield Village this week. He did not enter the field before last week's deadline and is presumably not healthy enough to tee it up with the best golfers in the world.
This tells me any faint hope that Woods would play the U.S. Open at Oakmont is also out the window.
Woods entered the British Open field but that was more of a precaution and formality than anything else. It's difficult to see Woods playing that tournament either, which leads us back to what I've (mostly) thought this entire year -- that we are not going to see Woods play again until 2017 (and that we may never see him again).
"If I knew, I'd tell you, because it'd be fun to know," Woods said at Congressional in a press conference for the QuickenLoans National earlier this month. "It'd be nice to know that I am going to play on such-and-such a date. But I don't know."
The news recently got worse for Woods, too. He lost his bag sponsor, MusclePharm. According to Darren Rovell, MusclePharm paid Woods off early to end the relationship.
The company disclosed in a filing to the Securities and Exchange Commission on Wednesday that it entered a deal on May 19 with Woods' company, ETW Corp. The company said in the filing that from July 1, 2014, to March 31, 2016, the company paid Woods $7 million. To settle the deal, the company disclosed it paid an additional $2.5 million.
This would appear to have more to do with MusclePharm saving money than Woods not playing, but it's still not great news for Big Cat.